Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Cells|April 12, 2022
Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell MalignanciesKatia Beider, Orit Itzhaki, Jacob Schachter, et al.
Blood Advances|January 4, 2018
Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathwaysSheryl M Gough, Liat Goldberg, Marbin Pineda, et al.
The Lancet. Haematology|September 9, 2022
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort studySara Ghorashian, Elad Jacoby, Barbara De Moerloose, et al.
Transplantation and Cellular Therapy|July 2, 2023
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell FailureElizabeth M Holland, Bonnie Yates, Seth M Steinberg, et al.
Hemasphere|December 10, 2025
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statementAdam Lamble, Sandra D Bohling, Kara L Davis, et al.
Leukemia|October 31, 2022
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemiaValeria Ceolin, Erica Brivio, Harm van Tinteren, et al.
Genes|November 27, 2025
A Nationwide Analysis of the Phenotype/Genotype Landscape of Hemophagocytic Lymphohistiocytosis: UNC13D Associates with Poor PrognosisDafna Brik Simon, Yarden Greental Ness, Orly Dgany, et al.
Leukemia|April 26, 2022
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international studyElad Jacoby, Sara Ghorashian, Britta Vormoor, et al.
Nature Communications|July 28, 2016
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticityElad Jacoby, Sang M Nguyen, Thomas J Fountaine, et al.
The Journal of Clinical Investigation|June 4, 2013
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growthYael Nemlich, Eyal Greenberg, Rona Ortenberg, et al.
Pageof 9